Zobrazeno 1 - 10
of 12
pro vyhledávání: '"RC254-282"'
Publikováno v:
Discover Oncology, Vol 12, Iss 1, Pp 1-11 (2021)
Discover. Oncology
Discover. Oncology
Dysregulation of microRNAs (miRNAs) exerts key roles in the development of pancreatic cancer (PCa). miR-26a is reportedly a tumor suppressor in cancers. However, whether miR-26a modulates PCa progression is poorly understood. Here, we found that miR-
Autor:
Yueling Wu, Hui Luo, Qingyu Zhang, Ying Zhang, Xingmei Jiang, Chengfeng Ye, Ning Li, Baoyuan Zhang
Publikováno v:
Discover Oncology, Vol 12, Iss 1, Pp 1-15 (2021)
Discover. Oncology
Discover. Oncology
Kinases are the ideal druggable targets for diseases and especially were highlighted on cancer therapy. Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase and its aberrant signaling extensively implicates in the progression of most cancer
Publikováno v:
Discover Oncology, Vol 12, Iss 1, Pp 1-24 (2021)
Discover. Oncology
Discover. Oncology
Prevalent dysregulation of epigenetic modifications plays a pivotal role in cancer. Targeting epigenetic abnormality is a new strategy for cancer therapy. Understanding how conventional oncogenic factors cause epigenetic abnormality is of great basic
Publikováno v:
Discover Oncology, Vol 12, Iss 1, Pp 1-11 (2021)
Discover. Oncology
Discover. Oncology
Globally, prostate cancer ranks second in cancer burden of the men. It occurs more frequently in black men compared to white or Asian men. Usually, high rates exist for men aged 60 and above. In this review, we focus on the Wnt/β-catenin signal tran
Publikováno v:
Discover Oncology, Vol 12, Iss 1, Pp 1-15 (2021)
Discover. Oncology
Discover. Oncology
Frizzled (FZD) transmembrane receptors are well known for their role in β-catenin signaling and development and now understanding of their role in the context of cancer is growing. FZDs are often associated with the process of epithelial to mesenchy
Autor:
Samina Badar, Sarah J. Valle, David L. Morris, Kevin Ke, Javed Akhter, Ahmed H. Mekkawy, Krishna Pillai
Publikováno v:
Discover Oncology, Vol 12, Iss 1, Pp 1-11 (2021)
Discover. Oncology
Discover. Oncology
Intraperitoneal administration of BromAc (bromelain + acetylcysteine) is currently undergoing a phase 1 clinical trial for pseudomyxoma peritonei at our institution. This study reports on analysis of routine blood parameters before and after treatmen
Publikováno v:
Discover Oncology, Vol 12, Iss 1, Pp 1-11 (2021)
Discover. Oncology
Discover. Oncology
ObjectivesWe described incidence trends of keratinocyte carcinomas (KCs)—namely basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)—in the Australian state of Tasmania.MethodsWe identified histologically confirmed KCs within the Tasmania
Publikováno v:
Discover Oncology, Vol 12, Iss 1, Pp 1-14 (2021)
Discover. Oncology
Discover. Oncology
Background To evaluate the association of primary tumor size with clinicopathologic characteristics and survival of patients with squamous cell carcinoma of the penis (SCCP). Methods This study analyzed the data of 1001 patients with SCCP, obtained f
Autor:
Lars Hanker, Udo Schumacher, Volkmar Müller, Frederik Marmé, Valentina Nekljudova, Peter A. Fasching, Rolf-Peter Henke, Christian Schem, Valentina Vladimirova, Sibylle Loibl, Karin Milde-Langosch, Sabine Schmatloch, Thomas Karn, Elmar Stickeler, Volker Möbus, Christine Stürken, Claus-Henning Köhne, Josef Rüschoff, Carsten Denkert
Publikováno v:
BMC cancer 21(1), 920 (2021). doi:10.1186/s12885-021-08656-0
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC cancer 21(1), 920 (2021). doi:10.1186/s12885-021-08656-0
Published by Springer, Berlin ; Heidelberg
Published by Springer, Berlin ; Heidelberg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2369003b5100c335d479a6cbb4ec4f6e
https://publications.rwth-aachen.de/record/851063
https://publications.rwth-aachen.de/record/851063
Publikováno v:
Discover oncology 12(1), 27 (2021). doi:10.1007/s12672-021-00422-9
Discover Oncology, Vol 12, Iss 1, Pp 1-9 (2021)
Discover. Oncology
Discover Oncology, Vol 12, Iss 1, Pp 1-9 (2021)
Discover. Oncology
Cancer immunotherapy represents a major advance in the cure of cancer following the dramatic advancements in the development and refinement of chemotherapies and radiotherapies. In the recent decades, together with the development of early diagnostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae88216f90454aa79198def2b7daa6ba
https://pub.dzne.de/record/163304
https://pub.dzne.de/record/163304